Europe q-PCR Reagents Market, By Detection Type (Dye-Based Reagents and Probe-Based Reagents), Assay Type (q-PCR Singleplex Test/Assay and q-PCR Multiplex Test/Assay), Plexity (Dye-Based Reagents, and Probe-Based Reagents), Packaging Type (Kits, and Master Mixers), Technology (Gene Expression, Gene Typing, MIRNA Analysis, Pre-Amplification, and Virus Detection), Application (Research, Diagnostics, and Forensic), End-User (Research & Academic Institute, Hospitals, Clinical Research Organization, Forensic Laboratories, and Others), Distribution Channel (Direct Tender, Third Party Distributors, and Others) - Market Trends and Forecast to 2029.
Europe q-PCR Reagents Market Analysis and Insights
Europe q-PCR reagents market is expected to gain significant growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.5% in the forecast period of 2022 to 2029 and is expected to reach USD 465.07 million by 2029. The major factor driving the growth of the Europe q-PCR reagents market is the increasing number of chronic diseases and communicable diseases.
Europe q-PCR reagents market report provides details of market share, new developments, and the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, products approvals, strategic decisions, product launches, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2019- 2014) |
|
Quantitative Units |
Revenue in USD Million |
|
Segments Covered |
By Detection Type (Dye-Based Reagents and Probe-Based Reagents), Assay Type (q-PCR Singleplex Test/Assay and q-PCR Multiplex Test/Assay), Plexity (Dye-Based Reagents, and Probe-Based Reagents), Packaging Type (Kits, and Master Mixers), Technology (Gene Expression, Gene Typing, MIRNA Analysis, Pre-Amplification, and Virus Detection), Application (Research, Diagnostics, and Forensic), End-User (Research & Academic Institute, Hospitals, Clinical Research Organization, Forensic Laboratories, and Others), Distribution Channel (Direct Tender, Third Party Distributors, and Others) |
|
Countries Covered |
Germany, U.K., France, Italy, Spain, Netherlands, Switzerland, Belgium, Poland, Austria, Ireland, Hungary, Norway, Russia, Turkey, Lithuania, And Rest Of Europe |
|
Market Players Covered |
Bio-Rad Laboratories, Inc., Agilent Technologies, Inc, Biotium, MiRXES Pte Ltd, GeneDireX, Inc, F. Hoffmann-La Roche Ltd, Norgen Biotek Corp, Takara Holdings Inc., Enzo Biochem Inc, Qiagen, PCR Biosystems, Quantabio, Merck KgaA, Kaneka Eurogentec S.A, Promega Corporation, Solis BioDyne, Seegene Inc., Sino Biological Inc, Thermo Fisher Scientific Inc, New England Biolabs, YouSeq Ltd, and Bioneer Corporation |
Market Definition
q-PCR reagents are used in the simultaneous amplification and detection/quantification of nucleic acids using the polymerase chain reaction (PCR). These reagents are used in different applications such as research, diagnosis, and forensics. They are also used for the detection of viruses, genetic stability testing, and others. The main advantage of q-PCR is that it allows you to determine the initial number of copies of template DNA (the amplification target sequence) with accuracy and high sensitivity over a wide dynamic range.
Europe q-PCR Reagents Market Dynamics
Drivers
- Increase in chronic diseases and communicable diseases
These diseases include cardiac diseases, cancer, and diabetes, which are the leading causes of death and disability in Europe.
q-PCR reagents are essential for the diagnosis of chronic diseases such as human Immuno Deficiency Virus (HIV) and malaria. Both conditions have non-specific symptoms. The q-PCR kits and mixers contain all the necessary PCR reagents for rapid, sensitive, and reproducible real-time detection of HIV and other diseases using highly specific primer pairs.
- Increase in the geriatric population
The geriatric population is susceptible to chronic and malignant diseases. The non-specific antibodies are more in the elderly population. The diagnosis through q-PCR reagents is important for the elderly population as it provides early diagnosis, which is crucial to prevent the extensive spread of the disease since the test is non-invasive and it aids in determining antigen detection in chronic infectious diseases.
There were approx.—1 million persons aged 65 years or over in Europe in 2022. The number of older persons is projected to double to 1.5 billion in 2050. Since the senior population is increasing hence the need for q-PCR reagents will also increase.
Opportunities
- The rise in government funding for healthcare
The government, federations, and major market players are creating opportunities across Europe. These initiatives by the players and government are helping the users reach out to take advantage of the policies made for low-income and developing nations and making them aware of preventable diseases if diagnosed earlier.
- The rise in healthcare expenditure
Increasing healthcare expenditure and infrastructure can help the patient take hassle-free advanced treatment to receive better diagnoses, procedures, and fast recovery. The spending on health is made up of the combination of out-of-pocket payments (people paying for their care), government expenditure, and sources, including health insurance and activities by non-governmental organizations.
An increase in healthcare expenditure and maintaining a good infrastructure has allowed end-users to adopt advanced q-PCR devices. An increase in the healthcare infrastructure is also impacted by to increase in the adoption of advanced q-PCR devices in hospitals and diagnostic centers for providing detailed imaging examinations for better diagnosis. Improving infrastructure development activities for the installation of new advanced technology-based products for diagnostic procedures and more healthcare expenditure are the factors changing R&D models in research-based for the adoption of the latest product in the hospital and providing better diagnosis results.
Restraints/Challenges
- High Cost of product
Modern technology reagents and devices lead to the high cost of treatment. The reagents and kits require a huge cost for the development process. The supply of raw materials, the regulatory process, and others also add up to the cost of the products. Additionally, the process is time-consuming as it needs sufficient time to fully mature before bringing into the market for use.
Furthermore, any changes that must be re-verified will impact time, and the growing advancements need an effective investment for successful operations along with a project risk management plan. The establishment of R&D for conducting research entails high costs, which in turn leads to expensive point-of-care devices. Thus, this factor is acting as a major restrain for the market
- Advancement in the field of genomics
The advancement in the field of the Human Genome or genomics by discovering sequences in the 3 billion letters of the genetic code made it possible for scientists to study and understand the factors that played a role in disease development. Also, in recent years many new prevention and treatment strategies have been discovered, which have decreased the market of q-PCR reagents as this genomics provides better results in a short period with lesser complications.
- Operational barriers faced in conducting diagnostic tests
Recent advances in the field of diagnostics may be related to kits, instruments, reagents, control, or any other, and it is not easy to adapt to the new advancement and techniques of healthcare professionals. To make structural decisions and précised results in diagnostics, organizations need to conduct training sessions for healthcare professionals to overcome and avoid errors in diagnosis.
Rural, developing, and low-income countries in the region do not have enough infrastructures to maintain the new kits and for sample storage as well. This is because of the limited supply of electricity and lack and education and awareness among healthcare professionals in the handling of new kits and reagents. This leads to errors in the diagnosis results and can lead to certain deaths, and can become a threat to the carrier of the individual performing the test.
The gender ratio and the age of healthcare professionals are raging and affecting the diagnostic workforce in many regions. Also, due to the risks associated with the profession of dealing with infectious disease-suffering patients or ethical issues, they are acting as a barrier in conducting the tests and diagnosis.
These barriers related to conducting the diagnostics test may affect the life of the populations, and this is one of the most difficult parts to overcome in low-income countries. Thus this is affecting the diagnostics community and acting as a challenge for the Europe q-PCR reagents market.
Europe q-PCR Reagents Market Scope
Europe q-PCR reagents market is categorized based on detection type, assay type, plexity, packaging type, application, technology, end user and distribution channel. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Detection Type
- Dye-based reagents
- Probe-based reagents
Based on detection type, the Europe q-PCR reagents market is classified into dye-based reagents and probe-based reagents.
Assay Type
- q-PCR singleplex test/assay
- q-PCR multiplex test/assay
Based on the assay type, the Europe q-PCR reagents market is classified into q-PCR singleplex test/assay and q-PCR multiplex test/assay.
Plexity
- Dye-based reagents
- Probe-based reagents
Based on plexity, the Europe q-PCR reagents market is classified into dye-based reagents and probe-based reagents.
Packaging Type
- Kits
- Master mixes
Based on packaging type, the Europe q-PCR reagents market is classified into kits and master mixes.
Technology
- Gene expression
- Gene typing
- MIRNA analysis
- Pre-amplification
- Virus detection
Based on technology, the Europe q-PCR reagents market is classified into gene expression, gene typing, MIRNA analysis, pre-amplification, and virus detection.
Application
- Diagnostics
- Research
- Forensic
On the basis of application, the Europe q-PCR reagents market is segmented into diagnostics, research, and forensics.
End User
- Hospital & diagnostic centers
- Forensic laboratories
- Research & academic institute
- Clinical research organization
- Others
On the basis of end user, the Europe q-PCR reagents market is segmented into hospital & diagnostic centers, forensic laboratories, research & academic institute, clinical research organization and others.
Distribution Channel
- Direct tender
- Third party distributors
- Others
On the basis of distribution channel, the Europe q-PCR reagents market is segmented into direct tender, third-party distributors and others.
Europe q-PCR Reagents Market Regional Analysis/Insights
Europe q-PCR reagents market is segmented on the basis of detection type, assay type, plexity, packaging type, application, technology, end user and distribution channel.
The countries in the Europe q-PCR reagents market are Germany, U.K., France, Italy, Spain, Netherlands, Switzerland, Belgium, Poland, Austria, Ireland, Hungary, Norway, Russia, Turkey, Lithuania, and Rest of Europe.
Germany is dominating the Europe q-PCR reagents market in terms of market share and market revenue due to the strong presence of market players in the country and the rising prevalence of communicable diseases such as HIV and others.
The country section of the report also provides individual market-impacting factors and market regulation changes that impact the market's current and future trends. Data point downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
SKU-
